UBS Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $351 | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $7K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $45K | Sell |
|
|||||
|
2021
Q3 | $466K | Buy |
|
|||||
|
2021
Q2 | $251K | Sell |
|
|||||
|
2021
Q1 | $1.19M | Buy |
|
|||||
|
2020
Q4 | $46K | Buy |
|
|||||
|
2020
Q3 | $6K | Sell |
|
|||||
|
2020
Q2 | $79K | Sell |
|
|||||
|
2020
Q1 | $53K | Sell |
|
|||||
|
2019
Q4 | $206K | Buy |
|
|||||
|
2019
Q3 | $135K | Buy |
|
|||||
|
2019
Q2 | $23K | Buy |
|
|||||
|
2019
Q1 | $1K | Buy |
|